Ipsen
The Lead Clinical Development Director, Rare will provide clinical, scientific, and strategic expertise to support drug development programs from lead compound identification through product registration and launch. This role involves leading clinical study teams, ensuring the execution of Clinical Development Plans, and managing complex clinical matters within the Rare Disease therapeutic area. The position requires collaboration with internal and external stakeholders, including KOLs and regulatory authorities, to drive successful clinical trial execution and scientific communication.
Headquarters
Paris, Île-De-France, France
Company Size
5001-10000 employees
Founded
1929
Ipsen is a global biopharmaceutical company focused on innovation and specialty care to improve the lives of patients around the world.
Headquarters
San Francisco, CA
Company Size
201-500 employees
Founded
2018
Industry
Technology
Glassdoor Rating
4.2 / 5
Sarah Johnson
Chief Executive Officer
Michael Chen
Chief Technology Officer
Emily Williams
VP of Engineering
David Rodriguez
VP of Product
Jessica Thompson
Chief Financial Officer
Andrew Park
VP of Sales
View leadership team, funding history,
and employee contacts for Ipsen.
Ipsen didn’t post a salary, so this is our estimate from similar listings.
IPSEN (OTCMKTS:IPSEY) Stock Crosses Above Two Hundred Day Moving Average - Here's What Happened
9 hours ago
VP, Clinical Science
Telix Pharmaceuticals
Medical Affairs (Rare Disease)
AstraZeneca
Global Development Medical Director, Late Respiratory and Immunology Clinical Development
American Association of Physicists in Medicine
Medical Director - US Rare
Sanofi
Rare Medical Engagement Manager
Sanofi
Clinical Research Director (CRD), Rare Diseases
Sanofi